Peripheral Vein

  • 3E03 Peripheral Vein
    • 3E030 Open
      • 3E0300 Antineoplastic
        • 3E03002 Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach
        • 3E03003 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach
        • 3E03005 Introduction of Other Antineoplastic into Peripheral Vein, Open Approach
        • 3E0300M Introduction of Monoclonal Antibody into Peripheral Vein, Open Approach
        • 3E0300P Introduction of Clofarabine into Peripheral Vein, Open Approach
      • 3E0301 Thrombolytic
        • 3E03016 Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open
        • 3E03017 Introduction of Other Thrombolytic into Peripheral Vein, Open Approach
      • 3E0302 Anti-infective
        • 3E03028 Introduction of Oxazolidinones into Peripheral Vein, Open Approach
        • 3E03029 Introduction of Other Anti-infective into Peripheral Vein, Open Approach
      • 3E0303 Anti-inflammatory
        • 3E0303Z Introduction of Anti-inflammatory into Peripheral Vein, Open Approach
      • 3E0304 Serum, Toxoid and Vaccine
        • 3E0304Z Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach
      • 3E0306 Nutritional Substance
        • 3E0306Z Introduction of Nutritional Substance into Peripheral Vein, Open Approach
      • 3E0307 Electrolytic and Water Balance Substance
        • 3E0307Z Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach
      • 3E030F Intracirculatory Anesthetic
        • 3E030FZ Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach
      • 3E030G Other Therapeutic Substance
        • 3E030GC Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach
        • 3E030GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach
      • 3E030H Radioactive Substance
        • 3E030HZ Introduction of Radioactive Substance into Peripheral Vein, Open Approach
      • 3E030K Other Diagnostic Substance
        • 3E030KZ Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach
      • 3E030N Analgesics, Hypnotics, Sedatives
        • 3E030NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach
      • 3E030P Platelet Inhibitor
        • 3E030PZ Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach
      • 3E030R Antiarrhythmic
        • 3E030RZ Introduction of Antiarrhythmic into Peripheral Vein, Open Approach
      • 3E030T Destructive Agent
        • 3E030TZ Introduction of Destructive Agent into Peripheral Vein, Open Approach
      • 3E030U Pancreatic Islet Cells
        • 3E030U0 Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
        • 3E030U1 Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
      • 3E030V Hormone
        • 3E030VG Introduction of Insulin into Peripheral Vein, Open Approach
        • 3E030VH Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach
        • 3E030VJ Introduction of Other Hormone into Peripheral Vein, Open Approach
      • 3E030W Immunotherapeutic
        • 3E030WK Introduction of Immunostimulator into Peripheral Vein, Open
        • 3E030WL Introduction of Immunosuppressive into Peripheral Vein, Open
      • 3E030X Vasopressor
        • 3E030XZ Introduction of Vasopressor into Peripheral Vein, Open Approach
    • 3E033 Percutaneous
      • 3E0330 Antineoplastic
        • 3E03302 Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
        • 3E03303 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
        • 3E03305 Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach
        • 3E0330M Introduction of Monoclonal Antibody into Peripheral Vein, Percutaneous Approach
        • 3E0330P Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach
      • 3E0331 Thrombolytic
        • 3E03316 Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous
        • 3E03317 Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach
      • 3E0332 Anti-infective
        • 3E03328 Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach
        • 3E03329 Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach
      • 3E0333 Anti-inflammatory
        • 3E0333Z Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach
      • 3E0334 Serum, Toxoid and Vaccine
        • 3E0334Z Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach
      • 3E0336 Nutritional Substance
        • 3E0336Z Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach
      • 3E0337 Electrolytic and Water Balance Substance
        • 3E0337Z Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach
      • 3E033F Intracirculatory Anesthetic
        • 3E033FZ Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach
      • 3E033G Other Therapeutic Substance
        • 3E033GC Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach
        • 3E033GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach
        • 3E033GQ Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach
      • 3E033H Radioactive Substance
        • 3E033HZ Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach
      • 3E033K Other Diagnostic Substance
        • 3E033KZ Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach
      • 3E033N Analgesics, Hypnotics, Sedatives
        • 3E033NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach
      • 3E033P Platelet Inhibitor
        • 3E033PZ Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach
      • 3E033R Antiarrhythmic
        • 3E033RZ Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach
      • 3E033T Destructive Agent
        • 3E033TZ Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach
      • 3E033U Pancreatic Islet Cells
        • 3E033U0 Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
        • 3E033U1 Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
      • 3E033V Hormone
        • 3E033VG Introduction of Insulin into Peripheral Vein, Percutaneous Approach
        • 3E033VH Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach
        • 3E033VJ Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach
      • 3E033W Immunotherapeutic
        • 3E033WK Introduction of Immunostimulator into Peripheral Vein, Percutaneous
        • 3E033WL Introduction of Immunosuppressive into Peripheral Vein, Percutaneous
      • 3E033X Vasopressor
        • 3E033XZ Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach